ARCHIVES

Ivax Paclitaxel To Remain On Market In Deal With BMS.

This article is from The Cancer Letter archive.

Vol. 28 No. 05 | February 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Board Approves Three Concepts

December 19, 2014

Doctor Files Defamation Suit Against Former Patient, But Legal Action Triggers Adverse Events

April 20, 2012

House Passes Cancer Bill With Mandates for NCI

September 28, 2012

In Brief: NCI Rushing To Complete Development Of Program Grants System By June 30

May 17, 1974

NCI Stops Trial Of Screening In Men To Add Women

November 2, 1990

In Brief DCCP Directorship Draws 100 Names; Upon Agrees Centers Programs Needs More Staff

January 13, 1978